Table 1 Physical and clinicopathological characteristics of the 137 patients included in the present study
Patient characteristics | N = patients (%) |
|---|---|
All | 137 |
Age (years) | |
  < 65 | 83 (60.5%) |
  ≥ 65 | 54 (39.5%) |
Gender | |
 Male | 99 (72.3%) |
 Female | 38 (27.7%) |
Histology | |
 Squamous | 71 (51.8%) |
 Non-squamous | 66 (48.2%) |
Performance Status (ECOG) | |
 0–1 | 95 (69.3%) |
 2–3 | 42 (30.7%) |
Driver gene | |
 Wild | 108 (78.8%) |
 Mutation | 29 (21.2%) |
Metastasis sites | |
  ≤ 3 | 73 53.3%) |
  > 3 | 64 (46.7%) |
Line(s) of treatment | |
 3 | 78 (56.9%) |
  > 3 | 59 (43.1%) |